Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure
Related Posts
Boghosian T, Burke OM, Kim IH, Joulfayan H, Williams K, Maskan Bermudez N, Tosti A. Social Media Misconceptions About Topical Minoxidil: A Mixed-Methods Evaluation of[...]
Miao KL, Huang MY, Guo L, Lung K, Armstrong AW. Effect of biologic use on the development of psoriatic arthritis: A population-based study. J Eur[...]
Yan MJ, Chou PP, Roberts AM, Jeong CY, Johnsen N, Katz A, Ma EJ, Nong Y, Armstrong AW. The Colors Beneath: More Than a Skin[...]